{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:21:28Z","timestamp":1782296488656,"version":"3.54.5"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T00:00:00Z","timestamp":1525996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Australian National Health and Medical Research Council","award":["#1022522"],"award-info":[{"award-number":["#1022522"]}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["#1041472"],"award-info":[{"award-number":["#1041472"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["#1073858"],"award-info":[{"award-number":["#1073858"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["#1013803"],"award-info":[{"award-number":["#1013803"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["#569738"],"award-info":[{"award-number":["#569738"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["#1045318"],"award-info":[{"award-number":["#1045318"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007281","name":"National Drug and Alcohol Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007281","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Government under the Substance Misuse Prevention and Service Improvements Grant Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1093\/pm\/pny078","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T11:10:56Z","timestamp":1525259456000},"page":"758-769","source":"Crossref","is-referenced-by-count":17,"title":["Concerns and Help-Seeking Among Patients Using Opioids for Management of Chronic Noncancer Pain"],"prefix":"10.1093","volume":"20","author":[{"given":"Briony","family":"Larance","sequence":"first","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Australia, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Campbell","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Australia, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teleri","family":"Moore","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Australia, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Australia, Sydney, New South Wales, Australia"},{"name":"The Langton Centre, South East Sydney Local Health District (SESLHD) Drug and Alcohol Services, Sydney New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimondo","family":"Bruno","sequence":"additional","affiliation":[{"name":"School of Medicine (Psychology), University of Tasmania, Hobart, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Lintzeris","sequence":"additional","affiliation":[{"name":"The Langton Centre, South East Sydney Local Health District (SESLHD) Drug and Alcohol Services, Sydney New South Wales, Australia"},{"name":"Addiction Medicine, Central Clinical School, University of Sydney, Camperdown, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Cohen","sequence":"additional","affiliation":[{"name":"St Vincent\u2019s Clinical School, UNSW Australia, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Hall","sequence":"additional","affiliation":[{"name":"Centre for Youth Substance Abuse, University of Queensland, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Mattick","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Australia, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"O\u2019Donnell","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Australia, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Degenhardt","sequence":"additional","affiliation":[{"name":"National Drug and Alcohol Research Centre, UNSW Australia, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,11]]},"reference":[{"issue":"10053","key":"key\n\t\t\t\t2019040110500536300_pny078-B1","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(16)31460-X","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE): A systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Kassebaum","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"key\n\t\t\t\t2019040110500536300_pny078-B2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1503\/cmaj.090784","article-title":"Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone","volume":"181","author":"Dhalla","year":"2009","journal-title":"Can Med Assoc J"},{"issue":"1","key":"key\n\t\t\t\t2019040110500536300_pny078-B3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/bcp.12937","article-title":"Twenty-five years of prescription opioid use in Australia: A whole-of-population analysis using pharmaceutical claims","volume":"82","author":"Karanges","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"key\n\t\t\t\t2019040110500536300_pny078-B4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a National Institutes of health pathways to prevention workshop effectiveness and risks of long-term opioid therapy for chronic pain","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"issue":"2","key":"key\n\t\t\t\t2019040110500536300_pny078-B5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","article-title":"Major increases in opioid analgesic abuse in the United States: Concerns and strategies","volume":"81","author":"Compton","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"key\n\t\t\t\t2019040110500536300_pny078-B6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/09595230600868504","article-title":"Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia","volume":"25","author":"Degenhardt","year":"2006","journal-title":"Drug Alcohol Rev"},{"issue":"5","key":"key\n\t\t\t\t2019040110500536300_pny078-B7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5694\/mja10.11450","article-title":"Prescription of opioid analgesics and related harms in Australia","volume":"195","author":"Roxburgh","year":"2011","journal-title":"Med J Aust"},{"issue":"1\u20132","key":"key\n\t\t\t\t2019040110500536300_pny078-B8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2009.03.021","article-title":"Opioid use behaviors, mental health and pain\u2014development of a typology of chronic pain patients","volume":"104","author":"Banta-Green","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"key\n\t\t\t\t2019040110500536300_pny078-B9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.pain.2010.02.037","article-title":"Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain","volume":"149","author":"Sullivan","year":"2010","journal-title":"Pain"},{"issue":"7","key":"key\n\t\t\t\t2019040110500536300_pny078-B10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/AJP.0b013e31823ade59","article-title":"Depression and ambivalence toward chronic opioid therapy for chronic non-cancer pain","volume":"28","author":"Howe","year":"2012","journal-title":"Clin J Pain"},{"issue":"1","key":"key\n\t\t\t\t2019040110500536300_pny078-B11","doi-asserted-by":"crossref","first-page":"1.","DOI":"10.1186\/2050-6511-15-17","article-title":"Cohort protocol paper: The Pain and Opioids IN Treatment (POINT) study","volume":"15","author":"Campbell","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"issue":"6","key":"key\n\t\t\t\t2019040110500536300_pny078-B12","doi-asserted-by":"crossref","first-page":"489.","DOI":"10.1097\/AJP.0b013e3181e103d9","article-title":"The prescribed opioids difficulties scale: A patient-centered assessment of problems and concerns","volume":"26","author":"Banta-Green","year":"2010","journal-title":"Clin J Pain"},{"issue":"1","key":"key\n\t\t\t\t2019040110500536300_pny078-B13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","article-title":"Core outcome measures for chronic pain clinical trials: IMMPACT recommendations","volume":"113","author":"Dworkin","year":"2005","journal-title":"Pain"},{"issue":"3","key":"key\n\t\t\t\t2019040110500536300_pny078-B14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pain.2003.08.001","article-title":"Core outcome domains for chronic pain clinical trials: IMMPACT recommendations","volume":"106","author":"Turk","year":"2003","journal-title":"Pain"},{"issue":"5","key":"key\n\t\t\t\t2019040110500536300_pny078-B15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1360-0443.1995.9056072.x","article-title":"The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users","volume":"90","author":"Gossop","year":"1995","journal-title":"Addiction"},{"issue":"5","key":"key\n\t\t\t\t2019040110500536300_pny078-B16","first-page":"270","article-title":"Estimation of cutoff for the Severity of Dependence Scale (SDS) for opiate dependence by ROC analysis","volume":"38","author":"Iraurgi Castillo","year":"2010","journal-title":"Actas Esp Psiquiatr"},{"issue":"159","key":"key\n\t\t\t\t2019040110500536300_pny078-B17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugalcdep.2015.11.026","article-title":"Development of an aberrant behavior scale for use in clinical and research settings: The Opioid-Related Behaviours In Treatment (ORBIT) scale","volume":"159","author":"Larance","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"key\n\t\t\t\t2019040110500536300_pny078-B18","author":"Cleeland","year":"1991"},{"issue":"3","key":"key\n\t\t\t\t2019040110500536300_pny078-B19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"key":"key\n\t\t\t\t2019040110500536300_pny078-B20","volume-title":"SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales.","author":"Ware","year":"1995"},{"issue":"9","key":"key\n\t\t\t\t2019040110500536300_pny078-B21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ\u20109","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"10","key":"key\n\t\t\t\t2019040110500536300_pny078-B22","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: The GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"6","key":"key\n\t\t\t\t2019040110500536300_pny078-B23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/pds.3945","article-title":"A synthesis of oral morphine equivalents (OME) for opioid utilisation studies","volume":"25","author":"Nielsen","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key\n\t\t\t\t2019040110500536300_pny078-B24","volume-title":"IBM SPSS Statistics for Windows, Version 22.0","author":"IBM Corporation","year":"2013"},{"issue":"1","key":"key\n\t\t\t\t2019040110500536300_pny078-B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"key\n\t\t\t\t2019040110500536300_pny078-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/AJP.0b013e31828e361b","article-title":"Do patient-perceived pros and cons of opioids predict sustained higher-dose use?","volume":"30","author":"Thielke","year":"2013","journal-title":"Clin J Pain"},{"issue":"5","key":"key\n\t\t\t\t2019040110500536300_pny078-B27","first-page":"CD011117","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","author":"Nielsen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"key\n\t\t\t\t2019040110500536300_pny078-B28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2017.0001","article-title":"Opioid agonist treatment for patients with dependence on prescription opioids","volume":"317","author":"Nielsen","year":"2017","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019040110500536300_pny078-B29","volume-title":"National Guidelines for Medication-Assisted Treatment of Opioid Dependence","author":"Gowing","year":"2014"},{"issue":"2","key":"key\n\t\t\t\t2019040110500536300_pny078-B30","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/dar.12601","article-title":"Perceived stigma and social support in treatment for pharmaceutical opioid dependence","volume":"37","author":"Cooper","year":"2018","journal-title":"Drug Alcohol Rev"},{"issue":"4","key":"key\n\t\t\t\t2019040110500536300_pny078-B31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/bmjspcare-2016-001126","article-title":"Pain management strategies for patients on methadone maintenance therapy: A systematic review of the literature","volume":"7","author":"Taveros","year":"2017","journal-title":"BMJ Support Palliat Care"},{"issue":"6","key":"key\n\t\t\t\t2019040110500536300_pny078-B32","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1037\/pha0000039","article-title":"Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain","volume":"23","author":"Worley","year":"2015","journal-title":"Exp Clin Psychopharm"},{"issue":"12","key":"key\n\t\t\t\t2019040110500536300_pny078-B33","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/pme.12520","article-title":"Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients","volume":"15","author":"Daitch","year":"2014","journal-title":"Pain Med"},{"key":"key\n\t\t\t\t2019040110500536300_pny078-B34","doi-asserted-by":"crossref","first-page":"ES59","DOI":"10.36076\/ppj.2012\/15\/ES59","article-title":"Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine","volume":"15(suppl 3)","author":"Daitch","year":"2012","journal-title":"Pain Physician"},{"issue":"5","key":"key\n\t\t\t\t2019040110500536300_pny078-B35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/01.mjt.0000160935.62883.ff","article-title":"Sublingual buprenorphine is effective in the treatment of chronic pain syndrome","volume":"12","author":"Malinoff","year":"2005","journal-title":"Am J Ther"},{"issue":"4","key":"key\n\t\t\t\t2019040110500536300_pny078-B36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7326\/M16-2666","article-title":"Can primary care practices help address the health crisis fueled by prescription opioids?","volume":"166","author":"Edelman","year":"2017","journal-title":"Ann Intern Med"},{"issue":"12","key":"key\n\t\t\t\t2019040110500536300_pny078-B37","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jamainternmed.2014.5302","article-title":"Primary care\u2013based buprenorphine taper vs maintenance therapy for prescription opioid dependence: A randomized clinical trial","volume":"174","author":"Fiellin","year":"2014","journal-title":"JAMA Intern Med"},{"key":"key\n\t\t\t\t2019040110500536300_pny078-B38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugalcdep.2016.05.010","article-title":"Primary care physicians\u2019 perspectives on the prescription opioid epidemic","volume":"165","author":"Kennedy-Hendricks","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"key\n\t\t\t\t2019040110500536300_pny078-B39","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/09540121.2017.1300634","article-title":"Integrated opioid substitution therapy and HIV care: A qualitative systematic review and synthesis of client and provider experiences","volume":"29","author":"Guise","year":"2017","journal-title":"AIDS Care"},{"issue":"1","key":"key\n\t\t\t\t2019040110500536300_pny078-B40","doi-asserted-by":"crossref","first-page":"40.","DOI":"10.1186\/s13033-015-0031-9","article-title":"Closing the treatment gap for mental, neurological and substance use disorders by strengthening existing health care platforms: Strategies for delivery and integration of evidence-based interventions","volume":"9","author":"Shidhaye","year":"2015","journal-title":"Int J Ment Health Syst"},{"issue":"1","key":"key\n\t\t\t\t2019040110500536300_pny078-B41","doi-asserted-by":"crossref","DOI":"10.1186\/2050-6511-15-17","article-title":"Cohort protocol: The Pain and Opioids IN Treatment (POINT) study","volume":"15","author":"Campbell","year":"2014","journal-title":"BMC Pharmacol Toxicol"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/20\/4\/758\/28256222\/pny078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T15:10:37Z","timestamp":1661094637000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/20\/4\/758\/4995322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,11]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,5,11]]},"published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pny078","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4]]},"published":{"date-parts":[[2018,5,11]]}}}